Αναστάσιος Καραμανάκος

439 total citations
13 papers, 126 citations indexed

About

Αναστάσιος Καραμανάκος is a scholar working on Rheumatology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Αναστάσιος Καραμανάκος has authored 13 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 3 papers in Pathology and Forensic Medicine and 3 papers in Epidemiology. Recurrent topics in Αναστάσιος Καραμανάκος's work include SARS-CoV-2 and COVID-19 Research (2 papers), Autoimmune Bullous Skin Diseases (2 papers) and Spondyloarthritis Studies and Treatments (2 papers). Αναστάσιος Καραμανάκος is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), Autoimmune Bullous Skin Diseases (2 papers) and Spondyloarthritis Studies and Treatments (2 papers). Αναστάσιος Καραμανάκος collaborates with scholars based in Greece, United Kingdom and Italy. Αναστάσιος Καραμανάκος's co-authors include Petros P. Sfikakis, Maria G. Tektonidou, Gerasimos Evangelatos, G. Fragoulis, Stylianos Panopoulos, Μαρία Παππά, Katerina Laskari, Dimitrios Vassilopoulos, Kalliopi Fragiadaki and Theognosia Vergou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Lara D. Veeken.

In The Last Decade

Αναστάσιος Καραμανάκος

12 papers receiving 125 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Αναστάσιος Καραμανάκος Greece 7 53 47 37 22 16 13 126
M. Cornalba Italy 4 72 1.4× 21 0.4× 27 0.7× 58 2.6× 2 0.1× 9 131
Ana Paula Monteiro Gomides Brazil 5 75 1.4× 22 0.5× 20 0.5× 20 0.9× 31 155
María Ángeles Blázquez-Cañamero Spain 5 26 0.5× 10 0.2× 45 1.2× 10 0.5× 2 0.1× 22 98
Patrícia Patrício Portugal 7 54 1.0× 25 0.5× 27 0.7× 24 1.1× 14 158
Melissa Tesher United States 8 30 0.6× 57 1.2× 54 1.5× 82 3.7× 19 180
Alice Fike United States 6 108 2.0× 61 1.3× 10 0.3× 9 0.4× 2 0.1× 11 147
Tali Eviatar Israel 7 38 0.7× 16 0.3× 22 0.6× 12 0.5× 1 0.1× 21 130
Fatima Barbar‐Smiley United States 6 33 0.6× 29 0.6× 6 0.2× 31 1.4× 4 0.3× 12 100
Christiane Weseloh Germany 7 64 1.2× 16 0.3× 14 0.4× 38 1.7× 14 117
Sherwin Navaz United States 4 25 0.5× 51 1.1× 62 1.7× 11 0.5× 5 141

Countries citing papers authored by Αναστάσιος Καραμανάκος

Since Specialization
Citations

This map shows the geographic impact of Αναστάσιος Καραμανάκος's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Αναστάσιος Καραμανάκος with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Αναστάσιος Καραμανάκος more than expected).

Fields of papers citing papers by Αναστάσιος Καραμανάκος

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Αναστάσιος Καραμανάκος. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Αναστάσιος Καραμανάκος. The network helps show where Αναστάσιος Καραμανάκος may publish in the future.

Co-authorship network of co-authors of Αναστάσιος Καραμανάκος

This figure shows the co-authorship network connecting the top 25 collaborators of Αναστάσιος Καραμανάκος. A scholar is included among the top collaborators of Αναστάσιος Καραμανάκος based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Αναστάσιος Καραμανάκος. Αναστάσιος Καραμανάκος is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Παππά, Μαρία, Αναστάσιος Καραμανάκος, Fabiola Atzeni, et al.. (2025). Similar Hepatitis B virus reactivation risk for patients with inflammatory arthritis or connective tissue diseases: a multicenter retrospective study. Rheumatology International. 45(1). 15–15.
2.
Καραμανάκος, Αναστάσιος, Dimitra Koumaki, Argyro Repa, et al.. (2024). Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients. Lupus. 33(11). 1248–1253. 3 indexed citations
3.
Καραμανάκος, Αναστάσιος, Olga Vougiouka, Aliki I. Venetsanopoulou, et al.. (2024). The expanding clinical spectrum of autoinflammatory diseases with NOD2 variants: a case series and literature review. Frontiers in Immunology. 15. 1342668–1342668. 8 indexed citations
4.
Καραμανάκος, Αναστάσιος, et al.. (2024). P100 Efficacy of anifrolumab in multi-refractory skin manifestations of systemic lupus erythematosus: case series. SHILAP Revista de lepidopterología. A112.2–A113. 1 indexed citations
5.
Koutsianas, Christos, Αναστάσιος Καραμανάκος, Κonstantinos Thomas, et al.. (2024). Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study. Lara D. Veeken. 64(4). 1989–1998. 4 indexed citations
6.
Καραμανάκος, Αναστάσιος, Maria G. Tektonidou, Olga Vougiouka, et al.. (2022). Autoinflammatory syndromes with coexisting variants in Mediterranean FeVer and other genes: Utility of multiple gene screening and the possible impact of gene dosage. Seminars in Arthritis and Rheumatism. 56. 152055–152055. 5 indexed citations
7.
Evangelatos, Gerasimos, Sizheng Steven Zhao, Αναστάσιος Καραμανάκος, et al.. (2022). Depression and anxiety in a real-world psoriatic arthritis longitudinal study: should we focus more on patients' perception?. Clinical and Experimental Rheumatology. 41(1). 159–165. 17 indexed citations
8.
Evangelatos, Gerasimos, Μαρία Παππά, Αναστάσιος Καραμανάκος, et al.. (2022). Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice. Therapeutic Advances in Musculoskeletal Disease. 14. 1759720X221122417–1759720X221122417. 11 indexed citations
9.
Panopoulos, Stylianos, Vasilios Tzilas, Vasiliki-Kalliopi Bournia, et al.. (2022). COVID-19 and protection of vaccination in patients with systemic sclerosis–associated interstitial lung disease. Journal of Scleroderma and Related Disorders. 8(2). 113–119. 3 indexed citations
10.
Fragoulis, G., Aikaterini Arida, Gerasimos Evangelatos, et al.. (2021). Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study. Rheumatology International. 41(5). 895–902. 14 indexed citations
11.
Fragoulis, G., Gerasimos Evangelatos, Kalliopi Fragiadaki, et al.. (2021). COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study. Rheumatology International. 42(1). 31–39. 34 indexed citations
12.
Καραμανάκος, Αναστάσιος, Theognosia Vergou, Stylianos Panopoulos, et al.. (2021). Psoriasis as an adverse reaction to biologic agents beyond anti-TNF-α therapy. European Journal of Dermatology. 31(3). 307–317. 15 indexed citations
13.
Fragoulis, G., Gerasimos Evangelatos, Aikaterini Arida, et al.. (2020). Nocebo-Prone Behaviour in Patients with Autoimmune Rheumatic Diseases during the COVID-19 Pandemic. Mediterranean Journal of Rheumatology. 31(Suppl 2). 288–288. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Cornalba Breakdown of academic impact, for papers by Ana Paula Monteiro Gomides Breakdown of academic impact, for papers by María Ángeles Blázquez-Cañamero Breakdown of academic impact, for papers by Patrícia Patrício Breakdown of academic impact, for papers by Melissa Tesher Breakdown of academic impact, for papers by Alice Fike Breakdown of academic impact, for papers by Tali Eviatar Breakdown of academic impact, for papers by Fatima Barbar‐Smiley Breakdown of academic impact, for papers by Christiane Weseloh Breakdown of academic impact, for papers by Sherwin Navaz
Rankless by CCL
2026